1. Home
  2. POCI vs RNXT Comparison

POCI vs RNXT Comparison

Compare POCI & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POCI
  • RNXT
  • Stock Information
  • Founded
  • POCI 1982
  • RNXT 2012
  • Country
  • POCI United States
  • RNXT United States
  • Employees
  • POCI N/A
  • RNXT N/A
  • Industry
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RNXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • POCI Health Care
  • RNXT Health Care
  • Exchange
  • POCI Nasdaq
  • RNXT Nasdaq
  • Market Cap
  • POCI 32.4M
  • RNXT 31.6M
  • IPO Year
  • POCI N/A
  • RNXT 2021
  • Fundamental
  • Price
  • POCI $5.06
  • RNXT $1.15
  • Analyst Decision
  • POCI
  • RNXT Strong Buy
  • Analyst Count
  • POCI 0
  • RNXT 1
  • Target Price
  • POCI N/A
  • RNXT $9.00
  • AVG Volume (30 Days)
  • POCI 8.6K
  • RNXT 195.7K
  • Earning Date
  • POCI 02-18-2025
  • RNXT 03-31-2025
  • Dividend Yield
  • POCI N/A
  • RNXT N/A
  • EPS Growth
  • POCI N/A
  • RNXT N/A
  • EPS
  • POCI N/A
  • RNXT N/A
  • Revenue
  • POCI $18,980,148.00
  • RNXT N/A
  • Revenue This Year
  • POCI N/A
  • RNXT N/A
  • Revenue Next Year
  • POCI N/A
  • RNXT N/A
  • P/E Ratio
  • POCI N/A
  • RNXT N/A
  • Revenue Growth
  • POCI N/A
  • RNXT N/A
  • 52 Week Low
  • POCI $3.47
  • RNXT $0.77
  • 52 Week High
  • POCI $6.90
  • RNXT $1.86
  • Technical
  • Relative Strength Index (RSI)
  • POCI 51.60
  • RNXT 58.08
  • Support Level
  • POCI $4.75
  • RNXT $1.32
  • Resistance Level
  • POCI $5.19
  • RNXT $1.40
  • Average True Range (ATR)
  • POCI 0.15
  • RNXT 0.11
  • MACD
  • POCI 0.01
  • RNXT 0.00
  • Stochastic Oscillator
  • POCI 58.49
  • RNXT 39.47

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: